AnPac Bio: Surges on development of new generation cancer detection sensor

Fresh2

09/03/2021 13:14

** U.S.-listed shares of Chinese biotech co  ANPC.O  jump
~80.6% to $10.48 pre-market; among top pct gainers across U.S.
exchanges
    ** Co says it has developed a new generation sensor for
multi-cancer detection (https://refini.tv/2Odx2je)
    ** The device, CDA Pro Sensor, reduced cost by ~137% and
both cancer detection sensitivity and specificity reached over
95% in a retrospective clinical sample test - ANPC
    ** Development and evaluations for sensor were completed at
end of February
    ** Up to Monday's close, U.S. stock had risen 9.4% this year

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))